Literature DB >> 23821206

Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.

Silvana Di Palma1.   

Abstract

Carcinoma ex pleomorphic adenoma (CXPA) is a broad category of carcinomas of the salivary glands which includes at least 2 clinically relevant categories; one is referred here as early CXPA (ECXPA), the other as widely invasive CXPA. The former includes several histological patterns ranging from non-invasive/in situ/intraductal/intratubular, early invasive/extratubular/intracapsular and extracapsular (up to 6 mm). The latter includes any CXPA with invasion of >6 mm. The clinical behaviour of ECXPA is not aggressive and tends to overlap that of a pleomorphic adenoma (PA) which makes the histological report of carcinoma contradictory. These early malignant changes in PA are known since the 1970s but it has been the use of immunohistochemical and molecular genetic analysis for HER-2 and TP53 gene in the last decade that has clarified the genuine malignant nature of the cells. HER-2 and TP53 gene and protein are involved in the early stages of malignant transformation of PA. Moreover the immunohistochemical over-expression HER-2, p53 protein and Mib-1 proliferation marker may be useful markers to identify malignant areas in PA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821206      PMCID: PMC3712089          DOI: 10.1007/s12105-013-0454-z

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  27 in total

1.  Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.

Authors:  J E Lewis; K D Olsen; T J Sebo
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

2.  Carcinoma ex pleomorphic adenoma: a clinicopathologic review.

Authors:  K D Olsen; J E Lewis
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

Review 3.  Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases.

Authors:  C A Waldron; S K el-Mofty; D R Gnepp
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1988-09

4.  Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes.

Authors:  M E Tortoledo; M A Luna; J G Batsakis
Journal:  Arch Otolaryngol       Date:  1984-03

5.  Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall.

Authors:  Alena Skalova; Albina Altemani; Silvana Di Palma; Roderick H W Simpson; Lubor Hosticka; Pavel Andrle; Jan Laco; Mary Toner; Marina A Vozmitsel; Susan Szakacs; Dmitry V Kazakov; Zdenek Kinkor; Michal Michal
Journal:  Am J Surg Pathol       Date:  2012-11       Impact factor: 6.394

Review 6.  Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study.

Authors:  V A LiVolsi; K H Perzin
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

7.  Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.

Authors:  Silvana Di Palma; Roderick H W Simpson; Caterina Marchiò; Alena Skálová; Marco Ungari; Ann Sandison; Stephen Whitaker; Suzanne Parry; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2012-10       Impact factor: 5.087

8.  Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases.

Authors:  R H Spiro; A G Huvos; E W Strong
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

9.  Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry.

Authors:  A Skálová; I Stárek; T Vanecek; V Kucerová; L Plank; P Szépe; S Di Palma; I Leivo
Journal:  Histopathology       Date:  2003-04       Impact factor: 5.087

10.  Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland.

Authors:  K Nagao; O Matsuzaki; H Saiga; I Sugano; H Shigematsu; T Kaneko; T Katoh; T Kitamura
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  20 in total

Review 1.  [Updates on tumours of the salivary glands : 2017 WHO classification].

Authors:  S Ihrler; O Guntinas-Lichius; C Haas; M Mollenhauer
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

2.  Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland.

Authors:  Leorik Pereira Silva; Luiz Arthur Barbosa da Silva; Bruno Tavares Sedassari; Suzana Cantanhede Orsini Machado de Sousa; Joabe Dos Santos Pereira; Lélia Batista de Souza; Márcia Cristina da Costa Miguel
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-29       Impact factor: 2.503

3.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.

Authors:  Leorik Pereira Silva; Thalita Santana; Bruno Tavares Sedassari; Suzana Machado de Sousa; Ana Paula Veras Sobral; Roseana de Almeida Freitas; Carlos Augusto Galvão Barboza; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-18       Impact factor: 2.503

5.  Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.

Authors:  N Chooback; Y Shen; M Jones; K Kasaian; M Martin; T Ng; T Thomson; M Marra; J Laskin; C Ho
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

6.  Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process.

Authors:  Stephan Ihrler; Orlando Guntinas-Lichius; Abbas Agaimy; Agnes Wolf; Martin Mollenhauer
Journal:  Virchows Arch       Date:  2017-03-28       Impact factor: 4.064

Review 7.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

8.  Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.

Authors:  Timo Atula; Jaana Hagström; Anttoni Markkanen; Katri Aro; Anna Ray Laury; Antti A Mäkitie; Caj Haglund
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

9.  Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.

Authors:  Miguel Rito; Isabel Fonseca
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

10.  Nasopharyngeal carcinoma ex-pleomorphic adenoma (noninvasive): A report of a rare case.

Authors:  Sujata Naik; Prateek Das; Rashmi Patnayak; Santosh Kumar Swain
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.